Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the use in this Amendment No. 1 to Registration Statement on Form S-1 of our report dated March 28, 2024, relating to the consolidated financial statements of Vivos Therapeutics, Inc. (the Company) (which report expresses an unqualified opinion and includes an explanatory paragraph relating to going concern uncertainty). We also consent to the reference to us under the heading “Experts” in such Registration Statement.

Denver, Colorado

January 28, 2025